To identify if responders were merely enriched in patients with better prognosis, we found response to atezolizumab, lymph node positivity, margin positivity, primary tumour size, the number of chemotherapy doses and density of intratumoural CD8+ T cells did not correlate with vaccine response (Extended Data Figs. 1b and 7c–e). Here, CD8A is linked to neoplasm.